Original Article · Originalarbeit
Anwendung komplementärer/alternativer Therapiemassnahmen bei Patientinnen mit BrustkrebsSchönekaes K.a · Micke O.a, b · Mücke R.a, c · Büntzel J.a,d · Glatzel M.a, e · Bruns F.a, f · Kisters K.a, g
aArbeitskreis «Trace Elements and Electrolytes in Radiation Oncology» (AKTE); bKlinik und Poliklinik für Strahlentherapie – Radioonkologie, Universitätsklinikum Münster; cAbteilung für Strahlentherapie, Radioonkologie und Nuklearmedizin, Klinikum Weiden; dHNO-Klinik, Südharz-Krankenhaus Nordhausen gGmbH, Nordhausen; eKlinik für Strahlentherapie, Zentralklinikum Suhl gGmbH; fKlinik für Radiologie, Clemenshospital, Münster; gInnere Medizin I, St. Anna-Hospital, Herne, Deutschland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Use of Complementary/Alternative Medicine by Patients with Breast Carcinoma Background: Complementary/alternative medicine (CAM) is gaining increasing importance especially in the treatment of patients with breast carcinoma. The purpose of this analysis was to investigate the prevalence of CAM in patients with breast carcinoma, to statistically describe the preparations and therapies used, and to determine the reasons for their use, the source of information and the individual perception. Patients and Methods: The statements of 203 patients with breast carcinoma who underwent radiotherapy were analyzed. The median age was 54 years (range 38–77 years). All patients underwent surgery as first therapy. 36 patients received a second-line radiotherapy because of metastases (27 patients) or local recurrence (9 patients). Results: 159 patients (78%) stated to carry out an additional treatment. 31 out of the 36 patients with metastases or local recurrence used CAM. Vitamin preparations (67%), mistletoe therapy (59%), and mineral preparations (33%) were used most frequently. 70% of the patients used a combination of two or more preparations/therapies. The most cited reason for using CAM was the aim of increasing quality of life (28%) and improving the immune system (27%). 72% stated an improvement of their individual perception. The main source of information was the general practitioner or the gynecologist. Conclusion: The radiotherapist has to take these complementary/alternative therapies into consideration; their importance should be evaluated in further studies.
© 2003 S. Karger GmbH, Freiburg
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.